MF Researcher Database

Researcher Database

Advance
Sakurai Reiko
Medical Oncology
Assistant Professor
Last Updated :2024/05/17

Researcher Profile and Settings

Researcher

  • Name

    Sakurai Reiko

Affiliation

  • Medical Oncology, Assistant Professor

Profile and Settings

  • Name

    Reiko, Sakurai

Alternate Names

  • 吉野麗子（reiko yoshino) （旧姓）
  • 櫻井麗子（reiko sakurai)

Affiliation

  • Gunma University, Assistant Professor

Affiliation

  • Affiliation

    Graduate School of Medicine

Degree

  • The degree of Doctor of Philosophy in Medical Sciences

Research Activities

Published Papers

  • Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report., Sunaga N, Miura Y, Sakurai R, Ohshima S, Uno S, Muto S, Sato M, Tsurumaki H, Yatomi M, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T., Apr. 2023, Anticancer Drugs., 34, 4, 605, 608, Scientific journal
  • Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer., Noriaki Sunaga, Yosuke Miura, Norimitsu Kasahara and Reiko Sakurai, Nov. 2021, Cancers, 13, 23, 5956
  • The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu, Yoshimasa; Koga, Yasuhiko; Sunaga, Noriaki; Kashiwagi, Chiharu; Sawada, Yuri; Saito, Yasuyuki; Tsukagoshi, Yusuke; Kasahara, Norimitsu; Sakurai, Reiko; Tsurumaki, Hiroaki; Yatomi, Masakiyo; Kaira, Kyoichi; Ono, Akihiro; Maeno, Toshitaka; Hisada, Takeshi, Jan. 2018, INTERNAL MEDICINE, 57, 2, 247, 251
    DOI
  • A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai, Reiko; Tomizawa, Yoshio; Yoshii, Akihiro; Miura, Yosuke; Tsurumaki, Hiroaki; Kaira, Kyoichi; Sunaga, Noriaki; Kawashima, Osamu; Hisada, Takeshi; Yamada, Masanobu; Saito, Ryusei, Jan. 2018, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81, 1, 103, 109
    DOI
  • The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura, Yosuke; Imai, Hisao; Sakurai, Reiko; Kaira, Kyoichi; Sunaga, Noriaki; Minato, Koichi; Saito, Ryusei; Hisada, Takeshi, Apr. 2018, MEDICAL ONCOLOGY, 35, 4, 45
    DOI
  • High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura, Yosuke; Kaira, Kyoichi; Sakurai, Reiko; Sunaga, Noriaki; Saito, Ryusei; Hisada, Takeshi; Yamada, Masanobu, Jan. 2018, LUNG CANCER, 115, 42, 48
    DOI
  • Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1, Kasahara, Norimitsu;Sunaga, Noriaki;Tsukagoshi, Yusuke;Miura, Yosuke;Sakurai, Reiko;Kitahara, Shinsuke;Yokobori, Takehiko;Kaira, Kyoichi;Mogi, Akira;Maeno, Toshitaka;Asao, Takayuki;Hisada, Takeshi, Mar. 2019, ANTICANCER RESEARCH, 39, 3, 1455, 1461
    DOI
  • Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer, Sunaga, Noriaki;Miura, Yosuke;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Masuda, Tomomi;Sakurai, Reiko;Kaira, Kyoichi;Hisada, Takeshi, Mar. 2019, ONCOLOGY LETTERS, 17, 3, 3569, 3575
    DOI
  • An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer, Kaira, Kyoichi;Imai, Hisao;Souma, Ryousuke;Sakurai, Reiko;Miura, Yosuke;Sunaga, Noriaki;Kasahara, Norimitsu;Tsukagoshi, Yusuke;Koga, Yasuhiko;Kitahara, Shinsuke;Kotake, Mie;Minato, Koichi;Naruse, Ichiro;Fukushima, Yasutsugu;Hisada, Takeshi;Ishizuka, Tamotsu, May 2019, ANTICANCER RESEARCH, 39, 5, 2483, 2491
    DOI
  • Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer, Kasahara, Norimitsu;Kaira, Kyoichi;Yamaguchi, Koichi;Masubuchi, Hiroaki;Tsurumaki, Hiroaki;Hara, Kenichiro;Koga, Yasuhiko;Sakurai, Reiko;Higuchi, Tetsuya;Handa, Tadashi;Oyama, Tetsunari;Yokobori, Takehiko;Shimizu, Kimihiro;Asao, Takayuki;Hisada, Takeshi, Jun. 2019, LUNG CANCER, 134, 180, 186
    DOI
  • Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study, Kasahara, Norimitsu;Sunaga, Noriaki;Kuwako, Tomohito;Naruse, Ichiro;Imai, Hisao;Jingu, Asuka;Tsukagoshi, Yusuke;Masuda, Tomomi;Kitahara, Shinsuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Hara, Kenichiro;Koga, Yasuhiko;Sakurai, Reiko;Mori, Keita;Kaira, Kyoichi;Maeno, Toshitaka;Asao, Takayuki;Hisada, Takeshi, Jan. 2020, SUPPORTIVE CARE IN CANCER, 28, 10, 4825, 4831
    DOI
  • Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer, Kotake, Mie;Kuwako, Tomohito;Imai, Hisao;Tomizawa, Yoshio;Kaira, Kyoichi;Yoshii, Akihiro;Ochiai, Mai;Miura, Yosuke;Osaki, Takashi;Sakurai, Reiko;Takei, Kousuke;Minato, Koichi;Saito, Ryusei, Jul. 2020, CHEMOTHERAPY, 65, 1-2, 21, 28
    DOI
  • Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin., Sakurai Reiko;Kaira Kyoichi;Miura Yosuke;Sunaga Noriaki;Saito Ryusei;Oyama Tetsunari;Hisada Takeshi;Yamada Masanobu, 03 Jan. 2020, Thoracic cancer, 11, 2, 426, 435
    DOI
  • A Case of Tracheobronchial Amyloidosis Complicated with Fibromyalgia, Systemic Scleroderma, and Sjögren Syndrome, Tsukagoshi Yusuke;Hisada Takeshi;Sawada Yuri;Hachisu Yoshimasa;Kasahara Norimitsu;Tsurumaki Hiroaki;Yatomi Masakiyo;Sakurai Reiko;Sunaga Noriaki;Maeno Toshitaka, 2019, The Journal of the Japan Society for Respiratory Endoscopy, 41, 2, 160, 163
  • Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report., Sasaki Yumeka;Koga Yasuhiko;Kasahara Norimitsu;Hachisu Yoshimasa;Murata Keisuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Tsukagoshi Yusuke;Sawada Yuri;Sakurai Reiko;Ono Akihiro;Sunaga Noriaki;Kaira Kyoichi;Hirato Junko;Maeno Toshitaka;Dobashi Kunio;Hisada Takeshi, 2018, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 85, 5, 291, 296
    DOI
  • 術後早期に脳転移にて再発し血清AFPの高値を認めた、気腫合併肺線維症に発症した高悪性度胎児肺型腺癌の1例, ;;;;;;;;;, Dec. 2015, 620回, 58
  • Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Miura, Yosuke;Kaira, Kyoichi;Sakurai, Reiko;Imai, Hisao;Tomizawa, Yoshio;Sunaga, Noriaki;Minato, Koichi;Hisada, Takeshi;Oyama, Tetsunari;Yamada, Masanobu, 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
    DOI
  • Combined inhibition of MEK and p38 efficiently inhibits cell growth of KRAS-mutated non-small cell lung cancer, Sunaga, Noriaki;Miura, Yosuke;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Sakurai, Reiko;Kaira, Kyoichi;Hisada, Takeshi, 2018, CANCER SCIENCE, 109, 587, 587
  • The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu, Yoshimasa;Koga, Yasuhiko;Sunaga, Noriaki;Kashiwagi, Chiharu;Sawada, Yuri;Saito, Yasuyuki;Tsukagoshi, Yusuke;Kasahara, Norimitsu;Sakurai, Reiko;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Kaira, Kyoichi;Ono, Akihiro;Maeno, Toshitaka;Hisada, Takeshi, 2018, INTERNAL MEDICINE, 57, 2, 247, 251
    DOI
  • Small Cell Lung Cancer with Sarcoidosis in Spontaneous Remission: A Case Report, Sasaki, Yumeka;Koga, Yasuhiko;Kasahara, Norimitsu;Hachisu, Yoshimasa;Murata, Keisuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Tsukagoshi, Yusuke;Sawada, Yuri;Sakurai, Reiko;Ono, Akihiro;Sunaga, Noriaki;Kaira, Kyoichi;Hirato, Junko;Maeno, Toshitaka;Dobashi, Kunio;Hisada, Takeshi, 2018, JOURNAL OF NIPPON MEDICAL SCHOOL, 85, 5, 291, 296
  • Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin, Sakurai, Reiko;Kaira, Kyoichi;Miura, Yosuke;Sunaga, Noriaki;Saito, Ryusei;Oyama, Tetsunari;Hisada, Takeshi;Yamada, Masanobu, 2020, THORACIC CANCER, 11, 2, 426, 435
    DOI
  • Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer, Sunaga, Noriaki;Miura, Yosuke;Kasahara, Norimitsu;Sakurai, Reiko, 2021, CANCERS, 13, 23
    DOI
  • Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis, Sunaga, Noriaki;Koga, Yasuhiko;Hachisu, Yoshimasa;Yamaguchi, Koichi;Aikawa, Masaki;Kasahara, Norimitsu;Miura, Yosuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Sakurai, Reiko;Maeno, Toshitaka;Hisada, Takeshi, 2022, CANADIAN RESPIRATORY JOURNAL, 2022
    DOI
  • Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations, Kanbe, Mio;Sunaga, Noriaki;Hara, Kenichiro;Sawada, Hiiru;Wakamatsu, Ikuo;Hara, Kentaro;Muto, Sohei;Sawada, Yuri;Masubuchi, Hiroaki;Sato, Mari;Miura, Yosuke;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Sakurai, Reiko;Koga, Yasuhiko;Ohtaki, Yoichi;Nagashima, Toshiteru;Okano, Naoko;Kubo, Nobuteru;Maeno, Toshitaka;Hisada, Takeshi, 2022, THORACIC CANCER
    DOI
  • 小細胞肺癌・1次化学療法の効果予測におけるBiP発現の意義, ;;;;;;;, Aug. 2020, 9, 増刊, 165
  • 多形紅斑を発症したため、Osimertinib減感作療法を行った肺腺癌の1例, ;;;;;;;;;;;, Aug. 2020, 9, 増刊, 174
  • 非小細胞肺癌患者を対象としたドセタキセル、ラムシルマブとペグフィルグラスチム併用療法の第II相試験, ;;;;;;;;;;;;;;;;;;, Oct. 2020, 60, 6, 581
  • Wnt/β-catenin経路活性化を介したLGR6過剰発現による肺癌の悪性形質獲得の分子制御機構, ;;;;;;;, Oct. 2020, 60, 6, 643
  • 神経内分泌腫瘍の血清マーカー高値の肺腺癌に対して姑息照射後の化学療法と免疫チェックポイント阻害薬の併用療法が著効した一例, ;;;;;;;;;;;;, Apr. 2021, 10, 増刊, 286
  • ドセタキセル+ラムシルマブ併用療法へのペグフィルグラスチム一次予防的投与を検討した第II相試験における高齢者サブグループ解析, ;;;;;;;;;;;;;;;;;;, Apr. 2021, 10, 増刊, 297
  • ニボルマブ治療後の7次治療としてのnab-パクリタキセル単剤療法が長期奏効した再発肺大細胞癌の1例, ;;;;;;;;;;;, Oct. 2021, 61, 6, 699
  • 進行胸腺癌全摘術後多発転移に対してレンバチニブを使用した一例, ;;;;;;;;;;;;, Sep. 2021, 180回・246回, 25
  • シングルユースの軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;, May 2022, 44, Suppl., S252
  • シングルユース軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 192
  • サルコイドーシスにおける血清NSEの診断的意義, ;;;;;;;;;;;, Apr. 2022, 11, 増刊, 221
  • Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer., Sunaga Noriaki;Miura Yosuke;Kasahara Norimitsu;Sakurai Reiko, 26 Nov. 2021, Cancers, 13, 23
    DOI
  • Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis., Sunaga Noriaki;Koga Yasuhiko;Hachisu Yoshimasa;Yamaguchi Koichi;Aikawa Masaki;Kasahara Norimitsu;Miura Yosuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Sakurai Reiko;Maeno Toshitaka;Hisada Takeshi, 26 May 2022, Canadian respiratory journal, 2022
    DOI
  • ニボルマブ治療後の7次治療としてのnab-パクリタキセル単剤療法が長期奏効した再発肺大細胞癌の1例, ;;;;;;;;;;;, Oct. 2021, 61, 6, 699
  • 進行胸腺癌全摘術後多発転移に対してレンバチニブを使用した一例, ;;;;;;;;;;;;, Sep. 2021, 180回・246回, 25
  • シングルユースの軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;, May 2022, 44, Suppl., S252
  • シングルユース軟性気管支鏡の有用性の検討, ;;;;;;;;;;;;;;;;;;;;;, Apr. 2022, 11, 増刊, 192
  • サルコイドーシスにおける血清NSEの診断的意義, ;;;;;;;;;;;, Apr. 2022, 11, 増刊, 221
  • 小細胞肺癌の異時性臀部転移に対して外科的切除を施行し、長期生存を得た1例, ;;;;;;;;;;, Jun. 2022, 62, 3, 271
  • Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report, Sunaga, Noriaki;Miura, Yosuke;Sakurai, Reiko;Ohshima, Sohei;Uno, Shogo;Muto, Sohei;Sato, Mari;Tsurumaki, Hiroaki;Yatomi, Masakiyo;Koga, Yasuhiko;Ohtaki, Yoichi;Nagashima, Toshiteru;Okano, Naoko;Kubo, Nobuteru;Maeno, Toshitaka;Hisada, Takeshi, 2023, ANTI-CANCER DRUGS, 34, 4, 605, 608
    DOI
  • 小細胞肺癌の異時性臀部転移に対して外科的切除を施行し、長期生存を得た1例, ;;;;;;;;;;, Jun. 2022, 62, 3, 271
  • オシメルチニブ耐性EGFR変異陽性肺腺癌の髄膜癌腫症に対してアファチニブが奏効した1例, ;;;;;;;;;;, Sep. 2022, 182回・251回, 39
  • 免疫チェックポイント阻害薬投与時の高齢者評価の有用性の検討, ;;, Oct. 2022, 60回, P8
  • 免疫併診プロジェクトチームにおける免疫チェックポイント阻害薬の有害事象について, ;;;;;;;, Oct. 2022, 60回, P8
  • S-1が奏効した胸腺癌の一例, ;;;;;;, Nov. 2022, 62, 6, 746
  • 当院におけるオンコマインDx Target TestマルチCDxシステムの現状と課題, ;;;;;;, Nov. 2022, 62, 6, 750
  • 再発胸腺癌に対するレンバチニブ治療の有効性および安全性に関する後方視的検討, ;;;;;;;;;;, Mar. 2023, 12, 増刊, 256
  • ニボルマブ/イピリムマブによるミオパチー,肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, ;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 279
  • トリプル吸入製剤におけるリアルワールドデータの解析について, ;;;;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 287
  • 当院における1次治療オシメルチニブ投与後のアファチニブ治療の後方視的検討, ;;;;;;;;;;, Mar. 2023, 12, 増刊, 301
  • EGFR変異陽性非小細胞肺癌に対するアファチニブ治療の後方視的検討, ;;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 303
  • 間質性腎炎,IgA腎症による腎機能障害を合併したEGFR変異陽性肺腺癌に対してアファチニブ治療が奏効した1例, ;;;;;;;, Mar. 2023, 12, 増刊, 355
  • Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations., Kanbe Mio;Sunaga Noriaki;Hara Kenichiro;Sawada Hiiru;Wakamatsu Ikuo;Hara Kentaro;Muto Sohei;Sawada Yuri;Masubuchi Hiroaki;Sato Mari;Miura Yosuke;Tsurumaki Hiroaki;Yatomi Masakiyo;Sakurai Reiko;Koga Yasuhiko;Ohtaki Yoichi;Nagashima Toshiteru;Okano Naoko;Kubo Nobuteru;Maeno Toshitaka;Hisada Takeshi, Oct. 2022, Thoracic cancer, 13, 22
    DOI
  • Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report., Sunaga Noriaki;Miura Yosuke;Sakurai Reiko;Ohshima Sohei;Uno Shogo;Muto Sohei;Sato Mari;Tsurumaki Hiroaki;Yatomi Masakiyo;Koga Yasuhiko;Ohtaki Yoichi;Nagashima Toshiteru;Okano Naoko;Kubo Nobuteru;Maeno Toshitaka;Hisada Takeshi, Dec. 2022, Anti-cancer drugs, 34, 4
    DOI
  • Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance., Sunaga Noriaki;Miura Yosuke;Masuda Tomomi;Sakurai Reiko, Feb. 2024, Cancers, 16, 4
    DOI
  • Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence., Ohtaki Yoichi;Nagashima Toshiteru;Okano Naoko;Kubo Nobuteru;Ohtaka Takeru;Sunaga Noriaki;Sakurai Reiko;Miura Yosuke;Nakazawa Seshiru;Kawatani Natsuko;Yazawa Tomohiro;Yoshikawa Ryohei;Narusawa Eiji;Shirabe Ken, Feb. 2024, Thoracic cancer
    DOI
  • 再発胸腺癌に対するレンバチニブ治療の有効性および安全性に関する後方視的検討, ;;;;;;;;;;, Mar. 2023, 12, 増刊, 256
  • ニボルマブ/イピリムマブによるミオパチー,肝障害にミコフェノール酸モフェチルが奏功した肺腺癌の一例, ;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 279
  • トリプル吸入製剤におけるリアルワールドデータの解析について, ;;;;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 287
  • 当院における1次治療オシメルチニブ投与後のアファチニブ治療の後方視的検討, ;;;;;;;;;;, Mar. 2023, 12, 増刊, 301
  • EGFR変異陽性非小細胞肺癌に対するアファチニブ治療の後方視的検討, ;;;;;;;;;;;;;;, Mar. 2023, 12, 増刊, 303
  • 間質性腎炎,IgA腎症による腎機能障害を合併したEGFR変異陽性肺腺癌に対してアファチニブ治療が奏効した1例, ;;;;;;;, Mar. 2023, 12, 増刊, 355
  • 肺癌におけるTescalcinの過剰発現とWnt/β-catenin経路活性化との関連性(Tescalcin overexpression and its relationship to Wnt/β-catenin pathway activation in lung cancer), ;;;;, Sep. 2023, 82回, 1818
  • IB-IIIA期NSCLCの術後補助化学療法の実際と今後, ;;;;;;;;;;, Oct. 2023, 63, 5, 504
  • EGFR変異陽性非小細胞肺癌に対する一次治療としてのアファチニブ単剤療法の有効性に関する後方視的検討, ;;;;;;;;;;;;;, Oct. 2023, 63, 5, 599
  • 当院における胸腺癌に対するレンバチニブの使用経験, ;;;;;;;;, Oct. 2023, 63, 5, 657
  • デュルバルマブ/エトポシド/シスプラチン療法で長期に病勢制御が得られた再発小細胞肺癌の1例, ;;;;;;;;, Oct. 2023, 63, 5, 658

MISC

  • Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene., Reiko Yoshino,Hisao Imai,Keita Mori,Kousuke Takei,Mai Tomizawa,Kyoichi Kaira,Akihiro Yoshii,Yoshio Tomizawa,Ryusei Saito,Masanobu Yamada, Sep. 2014, Molecular and clinical oncology, 2, 5, 731, 736
    DOI
  • Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene., Reiko Yoshino,Hisao Imai,Keita Mori,Kousuke Takei,Mai Tomizawa,Kyoichi Kaira,Akihiro Yoshii,Yoshio Tomizawa,Ryusei Saito,Masanobu Yamada, Sep. 2014, Molecular and clinical oncology, 2, 5, 731, 736
    DOI
  • First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations, Tomohito Kuwako,Hisao Imai,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Yoshino,Kyoichi Kaira,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Oct. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 761, 769
    DOI
  • First-line gefitinib treatment in elderly patients (aged >= 75 years) with non-small cell lung cancer harboring EGFR mutations, Tomohito Kuwako,Hisao Imai,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Yoshino,Kyoichi Kaira,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Oct. 2015, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 761, 769
    DOI
  • Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations, T. Masuda,H. Imai,T. Kuwako,Y. Miura,R. Yoshino,K. Kaira,K. Shimizu,N. Sunaga,Y. Tomizawa,S. Ishihara,A. Mogi,T. Hisada,K. Minato,A. Takise,R. Saito,M. Yamada, Sep. 2015, CLINICAL & TRANSLATIONAL ONCOLOGY, 17, 9, 702, 709
    DOI
  • Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations, T. Masuda,H. Imai,T. Kuwako,Y. Miura,R. Yoshino,K. Kaira,K. Shimizu,N. Sunaga,Y. Tomizawa,S. Ishihara,A. Mogi,T. Hisada,K. Minato,A. Takise,R. Saito,M. Yamada, Sep. 2015, CLINICAL & TRANSLATIONAL ONCOLOGY, 17, 9, 702, 709
    DOI
  • Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer, Reiko Yoshino,Hisao Imai,Keita Mori,Yoshio Tomizawa,Kosuke Takei,Mai Tomizawa,Kyoichi Kaira,Akihiro Yoshii,Satoru Watanabe,Ryusei Saito,Masanobu Yamada, Jul. 2015, JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 11, 3, 606, 611
    DOI
  • Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer, Reiko Yoshino,Hisao Imai,Keita Mori,Yoshio Tomizawa,Kosuke Takei,Mai Tomizawa,Kyoichi Kaira,Akihiro Yoshii,Satoru Watanabe,Ryusei Saito,Masanobu Yamada, Jul. 2015, JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 11, 3, 606, 611
    DOI
  • Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Yosuke Miura,Akihiro Yoshii,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Takeshi Hisada,Koichi Minato,Koji Sato,Toshifumi Kazama,Shinichi Ishihara,Kenya Kohyama,Naoto Fueki,Ryusei Saito,Noriaki Sunaga, Oct. 2013, LUNG CANCER, 82, 1, 103, 108
    DOI
  • Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Yosuke Miura,Akihiro Yoshii,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Takeshi Hisada,Koichi Minato,Koji Sato,Toshifumi Kazama,Shinichi Ishihara,Kenya Kohyama,Naoto Fueki,Ryusei Saito,Noriaki Sunaga, Oct. 2013, LUNG CANCER, 82, 1, 103, 108
    DOI
  • Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Akihiro Yoshii,Masana Matsuura,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Masaki Nishioka,Yosuke Kamide,Takeshi Hisada,Tamotsu Ishizuka,Katsuyuki Shirai,Takeshi Ebara,Jun-ichi Saitoh,Takashi Nakano,Noriaki Sunaga, Dec. 2013, LUNG CANCER, 82, 3, 449, 454
    DOI
  • Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Reiko Yoshino,Akihiro Yoshii,Masana Matsuura,Yasuki Iwasaki,Yasuhiko Koga,Akihiro Ono,Masaki Nishioka,Yosuke Kamide,Takeshi Hisada,Tamotsu Ishizuka,Katsuyuki Shirai,Takeshi Ebara,Jun-ichi Saitoh,Takashi Nakano,Noriaki Sunaga, Dec. 2013, LUNG CANCER, 82, 3, 449, 454
    DOI
  • Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine, Hisao Imai,Takehito Shukuya,Reiko Yoshino,Keiko Muraki,Keita Mori,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira,Hirotsugu Kenmotsu,Tateaki Naito,Haruyasu Murakami,Yoshio Tomizawa,Toshiaki Takahashi,Kazuhisa Takahashi,Ryusei Saito,Nobuyuki Yamamoto, 2013, CHEMOTHERAPY, 59, 4, 307, 313
    DOI
  • Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine, Hisao Imai,Takehito Shukuya,Reiko Yoshino,Keiko Muraki,Keita Mori,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira,Hirotsugu Kenmotsu,Tateaki Naito,Haruyasu Murakami,Yoshio Tomizawa,Toshiaki Takahashi,Kazuhisa Takahashi,Ryusei Saito,Nobuyuki Yamamoto, 2013, CHEMOTHERAPY, 59, 4, 307, 313
    DOI
  • Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients, Hisao Imai,Haruyasu Murakami,Reiko Yoshino,Keita Mori,Kiyomi Sumita,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira,Hirotsugu Kenmotsu,Hideyuki Harada,Tateaki Naito,Kyoichi Kaira,Yoshio Tomizawa,Yasuhisa Ohde,Masana Matsuura,Masahiro Endo,Ryusei Saito,Takashi Nakajima,Toshiaki Takahashi, Mar. 2016, JOURNAL OF BUON, 21, 2, 333, 340
  • Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients, Hisao Imai,Haruyasu Murakami,Reiko Yoshino,Keita Mori,Kiyomi Sumita,Akira Ono,Hiroaki Akamatsu,Tetsuhiko Taira,Hirotsugu Kenmotsu,Hideyuki Harada,Tateaki Naito,Kyoichi Kaira,Yoshio Tomizawa,Yasuhisa Ohde,Masana Matsuura,Masahiro Endo,Ryusei Saito,Takashi Nakajima,Toshiaki Takahashi, Mar. 2016, JOURNAL OF BUON, 21, 2, 333, 340
  • Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka,Takeshi Hisada,Motoaki Hatori,Akio Koike,Kikuo Hanabuchi,Shinichi Matsuzaki,Yosuke Kamide,Mitsuyoshi Utsugi,Haruka Aoki,Reiko Yoshino,Noriko Yanagitani,Yasuhiko Koga,Akihiro Ono,Kyoichi Kaira,Noriaki Sunaga,Kunio Dobashi,Takahiro Tsuburai,Kazuo Akiyama,Masanobu Yamada,Kazuhiro Suzuki,Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796
    DOI
  • Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka,Takeshi Hisada,Motoaki Hatori,Akio Koike,Kikuo Hanabuchi,Shinichi Matsuzaki,Yosuke Kamide,Mitsuyoshi Utsugi,Haruka Aoki,Reiko Yoshino,Noriko Yanagitani,Yasuhiko Koga,Akihiro Ono,Kyoichi Kaira,Noriaki Sunaga,Kunio Dobashi,Takahiro Tsuburai,Kazuo Akiyama,Masanobu Yamada,Kazuhiro Suzuki,Masatomo Mori, Sep. 2014, INFLAMMATION RESEARCH, 63, 9, 789, 796
    DOI
  • Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy, Mie Kotake,Yosuke Miura,Hisao Imai,Keita Mori,Reiko Sakurai,Kyoichi Kaira,Yoshio Tomizawa,Koichi Minato,Ryusei Saito,Takeshi Hisada, 2017, CHEMOTHERAPY, 62, 4, 205, 213
    DOI
  • Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy, Mie Kotake,Yosuke Miura,Hisao Imai,Keita Mori,Reiko Sakurai,Kyoichi Kaira,Yoshio Tomizawa,Koichi Minato,Ryusei Saito,Takeshi Hisada, 2017, CHEMOTHERAPY, 62, 4, 205, 213
    DOI
  • High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Oct. 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 5, 872, 879
    DOI
  • High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Oct. 2017, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 5, 872, 879
    DOI
  • Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer, Hisao Imai,Tomohito Kuwako,Kyoichi Kaira,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Sakurai,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Mar. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 3, 497, 505
    DOI
  • Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer, Hisao Imai,Tomohito Kuwako,Kyoichi Kaira,Tomomi Masuda,Yosuke Miura,Kaori Seki,Reiko Sakurai,Mitsuyoshi Utsugi,Kimihiro Shimizu,Noriaki Sunaga,Yoshio Tomizawa,Shinichi Ishihara,Takao Ishizuka,Akira Mogi,Takeshi Hisada,Koichi Minato,Atsushi Takise,Ryusei Saito,Masanobu Yamada, Mar. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 3, 497, 505
    DOI
  • Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Hisao Imai,Reiko Sakurai,Masana Matsuura,Akihiro Yoshii,Mai Ochiai,Mie Kotake,Takeshi Ebara,Jun-ichi Saitoh,Noriaki Sunaga,Koichi Minato,Ryusei Saito,Takeshi Hisada, Jan. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 1, 165, 171
    DOI
  • Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer, Kyoichi Kaira,Yoshio Tomizawa,Hisao Imai,Reiko Sakurai,Masana Matsuura,Akihiro Yoshii,Mai Ochiai,Mie Kotake,Takeshi Ebara,Jun-ichi Saitoh,Noriaki Sunaga,Koichi Minato,Ryusei Saito,Takeshi Hisada, Jan. 2017, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 79, 1, 165, 171
    DOI
  • Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Aug. 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
    DOI
  • Prognostic effect of class III beta-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors, Yosuke Miura,Kyoichi Kaira,Reiko Sakurai,Hisao Imai,Yoshio Tomizawa,Noriaki Sunaga,Koichi Minato,Takeshi Hisada,Tetsunari Oyama,Masanobu Yamada, Aug. 2017, ONCOLOGY LETTERS, 14, 2, 2369, 2378
    DOI
  • Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Yasuyuki Saito,Yuri Sawada,Yasuhiko Koga,Noriaki Sunaga,Yusuke Tsukagoshi,Yoshimasa Hachisu,Takashi Osaki,Reiko Sakurai,Kyoichi Kaira,Akihiro Ono,Ken Sato,Hiromi Koiso,Tetsunari Oyama,Takeshi Hisada,Masanobu Yamada, 2017, INTERNAL MEDICINE, 56, 20, 2753, 2757, Book review
    DOI
  • Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature, Yasuyuki Saito,Yuri Sawada,Yasuhiko Koga,Noriaki Sunaga,Yusuke Tsukagoshi,Yoshimasa Hachisu,Takashi Osaki,Reiko Sakurai,Kyoichi Kaira,Akihiro Ono,Ken Sato,Hiromi Koiso,Tetsunari Oyama,Takeshi Hisada,Masanobu Yamada, 2017, INTERNAL MEDICINE, 56, 20, 2753, 2757, Book review
    DOI
  • 胃瘻造設にて全身状態を改善し化学療法が継続できた原発性肺癌胃転移の1例．, 吉野麗子,富澤由雄,武井宏輔,桑子智人,吉井明弘,斎藤龍生, 2013, 2, 4, 375, 379
  • Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk, YASUAKI ENOKIDA,KIMIHIRO SHIMIZU,SEIICHI KAKEGAWA,JUN ATSUMI,YOSHIAKI TAKASE,YOHEI MIYAMAE,TOSHITERU NAGASHIMA,YOICHI OHTAKI,KYOICHI KAIRA,NORIAKI SUNAGA,NORIKO YANAGITANI,REIKO YOSHINO,KATSUHIKO TSUNEKAWA,HITOSHI IGAI,MITSUHIRO KAMIYOSHIHARA,KENGO USUI,ALEXANDER LEZHAVA,YOSHIO TOMIZAWA,TOSHIHISA ISHIKAWA,MASAMI MURAKAMI,YOSHIHIDE HAYASHIZAKI,IZUMI TAKEYOSHI, 2014, 2, 5, 719, 724
    DOI
  • The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura\, Yosuke,Imai\, Hisao,Sakurai\, Reiko,Kaira\, Kyoichi,Sunaga\, Noriaki,Minato\, Koichi,Saito\, Ryusei,Hisada\, Takeshi, 2018, 35, 4, 45
    DOI
  • A case of pulmonary tumor thrombotic microangiopathy improved by the treatment with prednisolone., Tomizawa Y,Yatomi M,Iwashina M,Yoshii A,Yoshino R,Takei K,Kuwako T,Tomizawa M,Kondo M,Saito R, 2013, 63, 3, 253, 255
    DOI
  • 当院職員において複数回行ったクォンティフェロン(R) TBゴールド検査の検討．, 土屋友規子,富澤由雄,渡邉覚,吉井明弘,吉野麗子,斎藤龍生, 2013, 2, 2, 101, 106
  • 気管・気管支内転移を認めた肺原発性腺癌の1例．, 吉野麗子,富澤由雄,武井宏輔,富澤麻衣,吉井明弘,斎藤龍生, 2014, 3, 5, 671, 674
  • Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy, Imai\, Hisao,Kaira\, Kyoichi,Mori\, Keita,Ono\, Akira,Akamatsu\, Hiroaki,Taira\, Tetsuhiko,Yoshino\, Reiko,Kenmotsu\, Hirotsugu,Saitoh\, Jun-ichi,Harada\, Hideyuki,Naito\, Tateaki,Murakami\, Haruyasu,Tomizawa\, Yoshio,Matsuura\, Masana,Saito\, Ryusei,Nakajima\, Takashi,Yamada\, Masanobu,Takahashi\, Toshiaki, 2015, 4, 152
    DOI
  • The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu\, Yoshimasa,Koga\, Yasuhiko,Sunaga\, Noriaki,Kashiwagi\, Chiharu,Sawada\, Yuri,Saito\, Yasuyuki,Tsukagoshi\, Yusuke,Kasahara\, Norimitsu,Sakurai\, Reiko,Tsurumaki\, Hiroaki,Yatomi\, Masakiyo,Kaira\, Kyoichi,Ono\, Akihiro,Maeno\, Toshitaka,Hisada\, Takeshi, 2018, 57, 2, 247, 251
    DOI
  • A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai\, Reiko,Tomizawa\, Yoshio,Yoshii\, Akihiro,Miura\, Yosuke,Tsurumaki\, Hiroaki,Kaira\, Kyoichi,Sunaga\, Noriaki,Kawashima\, Osamu,Hisada\, Takeshi,Yamada\, Masanobu,Saito\, Ryusei, 2018, 81, 1, 103, 109
    DOI
  • High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura\, Yosuke,Kaira\, Kyoichi,Sakurai\, Reiko,Sunaga\, Noriaki,Saito\, Ryusei,Hisada\, Takeshi,Yamada\, Masanobu, 2018, 115, 42, 48
    DOI
  • Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk, YASUAKI ENOKIDA,KIMIHIRO SHIMIZU,SEIICHI KAKEGAWA,JUN ATSUMI,YOSHIAKI TAKASE,YOHEI MIYAMAE,TOSHITERU NAGASHIMA,YOICHI OHTAKI,KYOICHI KAIRA,NORIAKI SUNAGA,NORIKO YANAGITANI,REIKO YOSHINO,KATSUHIKO TSUNEKAWA,HITOSHI IGAI,MITSUHIRO KAMIYOSHIHARA,KENGO USUI,ALEXANDER LEZHAVA,YOSHIO TOMIZAWA,TOSHIHISA ISHIKAWA,MASAMI MURAKAMI,YOSHIHIDE HAYASHIZAKI,IZUMI TAKEYOSHI, 2014, Biomedical Reports, 2, 5, 719, 724
    DOI
  • The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer, Miura\, Yosuke,Imai\, Hisao,Sakurai\, Reiko,Kaira\, Kyoichi,Sunaga\, Noriaki,Minato\, Koichi,Saito\, Ryusei,Hisada\, Takeshi, 2018, MEDICAL ONCOLOGY, 35, 4, 45
    DOI
  • A case of pulmonary tumor thrombotic microangiopathy improved by the treatment with prednisolone., Tomizawa Y,Yatomi M,Iwashina M,Yoshii A,Yoshino R,Takei K,Kuwako T,Tomizawa M,Kondo M,Saito R, 2013, The Kitakanto Medical Journal, 63, 3, 253, 255
    DOI
  • Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy, Imai\, Hisao,Kaira\, Kyoichi,Mori\, Keita,Ono\, Akira,Akamatsu\, Hiroaki,Taira\, Tetsuhiko,Yoshino\, Reiko,Kenmotsu\, Hirotsugu,Saitoh\, Jun-ichi,Harada\, Hideyuki,Naito\, Tateaki,Murakami\, Haruyasu,Tomizawa\, Yoshio,Matsuura\, Masana,Saito\, Ryusei,Nakajima\, Takashi,Yamada\, Masanobu,Takahashi\, Toshiaki, 2015, SPRINGERPLUS, 4, 152
    DOI
  • The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome, Hachisu\, Yoshimasa,Koga\, Yasuhiko,Sunaga\, Noriaki,Kashiwagi\, Chiharu,Sawada\, Yuri,Saito\, Yasuyuki,Tsukagoshi\, Yusuke,Kasahara\, Norimitsu,Sakurai\, Reiko,Tsurumaki\, Hiroaki,Yatomi\, Masakiyo,Kaira\, Kyoichi,Ono\, Akihiro,Maeno\, Toshitaka,Hisada\, Takeshi, 2018, INTERNAL MEDICINE, 57, 2, 247, 251
    DOI
  • A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer, Sakurai\, Reiko,Tomizawa\, Yoshio,Yoshii\, Akihiro,Miura\, Yosuke,Tsurumaki\, Hiroaki,Kaira\, Kyoichi,Sunaga\, Noriaki,Kawashima\, Osamu,Hisada\, Takeshi,Yamada\, Masanobu,Saito\, Ryusei, 2018, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81, 1, 103, 109
    DOI
  • High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin, Miura\, Yosuke,Kaira\, Kyoichi,Sakurai\, Reiko,Sunaga\, Noriaki,Saito\, Ryusei,Hisada\, Takeshi,Yamada\, Masanobu, 2018, LUNG CANCER, 115, 42, 48
    DOI

Presentations

  • EGFR変異陽性非小細胞肺癌に対するアファチニブ治療の後方視的検討, 原健太郎、砂長則明、横田暢、宇野翔吾、武藤壮平、相川政紀、澤田友里、佐藤麻里、三浦陽介、鶴巻寬朗、矢冨正清、櫻井麗子、古賀康彦、前野敏孝、久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • 当院における1次治療オシメルチニブ投与後のアファチニブ治療の後方視的検討, 横田暢、三浦陽介、砂長則明、増渕裕朗、佐藤麻里、鶴巻寬朗、矢冨正清、櫻井麗子、古賀康彦、久田剛志、前野敏孝, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • トリプル吸入製剤におけるリアルワールドデータの解析について, 星野裕紀、古賀康彦、宇野翔吾、若松郁生、原健太郎、武藤壮平、澤田友里、増渕裕朗、櫻井麗子、佐藤麻里、三浦陽介、鶴巻寬朗、矢冨正清、原健一郎、砂長則明、前野敏孝、久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • ニボルマブ/イピリムマブによるミオパチー、肝障害にミコフェノール酸モフェチルが奏効した肺腺癌の一例, 前野敏孝、原健太郎、宇野翔吾、武藤壮平、澤田友里、増田友美、増渕裕朗、三浦陽介、鶴巻寬朗、矢冨正清、櫻井麗子、古賀康彦、砂長則明、久田剛志, 第63回日本呼吸器学会学術講演会, 29 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • 再発胸腺癌に対するレンバチニブ治療の有効性及び安全性に関する後方視的検討, 砂長則明、三浦陽介、櫻井麗子、相川政紀、増田友美、佐藤麻里、鶴巻寬朗、矢冨正清、古賀康彦、前野敏孝、久田剛志, 第63回日本呼吸器学会学術講演会, 28 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • 間質性腎炎、IgA腎症による腎機能障害を合併したEGFR変異陽性肺腺癌に対してアファチニブ治療が奏効した1例, 櫻井麗子、三浦陽介、鶴巻寬朗、矢冨正清、古賀康彦、砂長則明、久田剛志、前野敏孝, 第63回日本呼吸器学会学術講演会, 30 Apr. 2023, 28 Apr. 2023, 30 Apr. 2023, Japanese
  • 当院におけるオンコマインDx Target TestマルチCDxシステムの現状と課題, 三浦　陽介、櫻井　麗子、鶴巻　寛朗、矢冨　正清、砂長　則明、久田　剛志、前野　敏孝, 第63回肺癌学会学術集会, 01 Dec. 2022, 01 Dec. 2022, 03 Dec. 2022, Japanese, Domestic conference
  • 免疫チェックポイント阻害薬投与時の高齢者評価の有用性の検討, 大崎 洋平、櫻井 麗子、塚本 憲史, 第60回癌治療学会, 20 Oct. 2022, 20 Oct. 2022, 22 Oct. 2022, English, Domestic conference
  • S-1が奏効した胸腺癌の一例, 櫻井 麗子 , 三浦 陽介, 鶴巻 寛朗, 矢冨 正清 , 砂長 則明, 久田 剛志, 前野 敏孝, 第63回日本肺癌学会学術集会, 03 Dec. 2022, 01 Dec. 2022, 03 Dec. 2022, Japanese, Domestic conference
  • Immune-related adverse events with immune checkpoint inhibitors, Reiko Sakurai, Yohei Osaki, Takehiro Shimizu, Katsuya Osone , Yusuke Miura, Sohei Oshima, Akemi Tsunoda, Norifumi Tukamoto, 第60回日本癌治療学会学術集会, 20 Oct. 2022, 20 Oct. 2022, 22 Oct. 2022, English, Domestic conference
  • A case of thymic cancer treated with chemotherapy of S-1., Reiko Sakurai, Norimitsu Kasahara, Yosuke Miura, Hiroaki Tsurumaki, Masakiyo Yatomi, Yasuhiko Koga, Noriaki Sunaga, Takeshi Hisada, Toshitaka Maeno, THE 25TH Congress of the Asia Pacific Society of Respirology., 20 Nov. 2021, 20 Nov. 2021, 21 Nov. 2021
  • Subgroup Analysis of a Phase II Trial of Pegfilgrastim as Primary Prophylactic Treatment for Docetaxel + Ramucirumab in Previously Treated Non-Small Cell Lung Cancer in the Elderly population, 笠原礼光，砂長則明，桑子智人，成清一郎，今井久雄，神宮飛鳥，塚越優介，増田友美，北原信介，鶴巻寛朗，矢冨正清，原健一郎，古賀康彦，櫻井麗子，盛啓太、解良恭一、前野敏孝、浅尾高行、久田剛志　, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, Japanese
  • A case of serum neuroendocrine marker-positive lung adenocarcinoma treated with chemotherapy plus immune checkpoint inhibitor followed by palliative radiotherapy, 申　悠樹，櫻井麗子，砂長則明，豊田正昂，小林　頂，相川政紀，佐藤麻里，高野峻一，鶴巻寛朗，原健一郎，古賀康彦，久田剛志，前野敏孝, 第61回日本呼吸器学会学術講演会, 23 Apr. 2021, Japanese
  • 免疫チェックポイント阻害薬治療患者に対する併診プロジェクトチームの取り組み, 櫻井麗子,関根宏美,大島宗平 ,笠原礼光,三浦陽介,大崎洋平,解良恭一,塚本憲史, 第16回日本臨床腫瘍学会学術集会, 20 Jul. 2018, 19 Jul. 2018, 21 Jul. 2018, Japanese, Domestic conference
  • Wnt/ β-catenin経路活性化を介したLGR6箇条発現による肺癌の悪性形質獲得の分子制御機構, 砂長則明,三浦陽介,伊藤優志,増田友美,笠原礼光,櫻井麗子,前野敏孝,久田剛志, 第61回日本肺癌学会学術集会, 12 Nov. 2020, 12 Nov. 2020, 14 Nov. 2020, Japanese, Domestic conference
  • 非小細胞肺癌患者を対象としたドセタキセル、ラムシルマブとペグフィルグラスチム併用療法の第Ⅱ相試験, 笠原礼光,砂長則明,桑子智人,成清一郎,今井久雄,神宮飛鳥,塚越優介,増田友美,北原信介,鶴巻寛朗,矢冨正清,原健一郎,古賀康彦,櫻井麗子,盛啓太,解良恭一,前野敏孝,浅尾高行く,久田剛志, 第61回日本肺癌学会学術集会, 13 Nov. 2020, 12 Nov. 2020, 14 Nov. 2020, Japanese, Domestic conference
  • 多形紅斑を発症したため、Osimertinib減感作療法を行った肺腺癌の1例, 伊藤優志,青木周平,笠原礼光,山口彩,山口公一,三浦陽介,鶴巻寛朗,矢冨正清,原健一郎,櫻井麗子,砂長則明,前野敏孝, 第60回日本呼吸器学会学術講演会, 20 Sep. 2020, 20 Sep. 2020, 22 Sep. 2020, Japanese, Domestic conference
  • 小細胞肺癌・一時化学療法の治療効果予測におけるBip発現の意義, 三浦陽介,解良恭一,櫻井麗子,笠原礼光,砂長則明,前野敏孝,齋藤龍生,久田剛志, 第60回日本呼吸器学会学術講演会, 20 Sep. 2020, 20 Sep. 2020, 22 Sep. 2020, Japanese, Domestic conference
  • Amrubicin投与非小細胞肺癌症例におけるTopoisomerase-I/II発現の臨床学的検討, 櫻井 麗子;解良 恭一;三浦 陽介;塚越 優介;笠原 礼光;砂長 則明;齋藤 龍生;久田 剛志, 第58回日本呼吸器学会学術講演会, 29 Apr. 2018, 27 Apr. 2018, 29 Apr. 2018, Japanese, Domestic conference
  • Pasteurella multocidaによる慢性肺炎の一例, 塚越 優介;蜂巣 克昌;青木 周平;原田 航;笠原 礼光;三浦 陽介;鶴巻 寛朗;矢冨 正清;櫻井 麗子;小野 昭浩;古賀 康彦;解良 恭一;砂長 則明;前野 敏孝;久田 剛志, 第58回日本呼吸器学会学術講演会, 2018, 27 Apr. 2018, 29 Apr. 2018, Japanese, Domestic conference
  • 閉塞性呼吸器疾患の増悪入院に影響を及ぼす肺機能、心機能パラメーターの検討, 鶴巻 寛朗;吉見 誠至;原田 孝;古賀 康彦;小野 昭浩;齋藤 悠;矢冨 正清;蜂巣 克昌;塚越 優介;笠原 礼光;佐藤 真季子;三浦 陽介;櫻井 麗子;砂長 則明;原 健一郎;前野 敏孝;久田 剛志, 第58回日本呼吸器学会学術講演会, 27 Apr. 2018, 27 Apr. 2018, 29 Apr. 2018, Japanese, Domestic conference
  • 非小細胞肺癌細胞においてKRAS/BRAF変異はMAPK/ERK経路を介してPD-L1発現を誘導する, 三浦 陽介;砂長 則明;包 品杰;解良 恭一;塚越 優介;笠原 礼光;増田 友美;櫻井 麗子;土橋 邦生;久田 剛志, 第60回日本呼吸器学会学術講演会, 28 Apr. 2018, 27 Apr. 2018, 29 Apr. 2018, Japanese, Domestic conference
  • シスプラチンを含む肺癌化学療法中に急性下肢動脈塞栓症を発症した一例, 笠原 礼光;青木 周平;矢冨 正清;原田 航;蜂巣 克昌;塚越 優介;三浦 陽介;鶴巻 寛朗;櫻井 麗子;古賀 康彦;小野 昭浩;解良 恭一;砂長 則明;前野 敏孝;久田 剛志, 第58回日本呼吸器学会学術講演会, 28 Apr. 2018, 27 Apr. 2018, 29 Apr. 2018, Japanese, Domestic conference
  • EGFR変異陽性非小細胞肺癌における治療前悪液質関連因子の予後予測因子としての意義, 塚越 優介;笠原 礼光;三浦 陽介;櫻井 麗子;砂長 則明;前野 敏孝;久田 剛志, 第59回日本肺癌学会学術集会, 29 Nov. 2018, 29 Nov. 2018, 01 Dec. 2018, Japanese, Domestic conference
  • 免疫関連副作用にてニボルマブ中止後も、持続する治療効果を認めた一例, 櫻井 麗子;塚越 優介;増田 友美;笠原 礼光;三浦 陽介;鶴巻 寛朗;矢冨 正清;古賀 康彦;砂長 則明;前野 敏孝;久田 剛志, 第59回日本肺癌学会学術集会, 30 Nov. 2018, 29 Nov. 2018, 01 Dec. 2018, Japanese, Domestic conference
  • 非小細胞肺癌細胞におけるWntシグナル伝達経路の恒常的活性化によるLGR6過剰発現(LGR6 overexpression induced by constitutive activation of the Wnt signaling pathway in NSCLC cells, 砂長 則明;三浦 陽介;解良 恭一;塚越 優介;櫻井 麗子;久田 剛志, 第77回日本癌学会学術集会, Sep. 2018, 27 Sep. 2018, 29 Sep. 2018, Domestic conference
  • SH法によるCDDP投与ではD-マンニトール、フロセミド併用は腎障害予防に必要か?, 関根 宏美;金城 妙子;中村 仁美;本多 理恵;櫻井 麗子;砂長 則明;塚本 憲史, 第56回日本癌治療学会学術集会, Oct. 2018, 18 Oct. 2018, 20 Oct. 2018, Japanese, Domestic conference
  • 完全寛解が得られた慢性骨髄性白血病治療継続中に発症した乳糜胸の一例, 大貫 祐史;原 健一郎;山口 公一;柏木 千春;竹原 和孝;青木 周平;塚越 優介;増田 友美;笠原 礼光;山口 彩;三浦 陽介;増渕 裕朗;北原 信介;鶴巻 寛朗;矢富 正清;櫻井 麗子;古賀 康彦;砂長 則明;前野 敏孝, 日本結核病学会関東支部学会・日本呼吸器学会関東地方会, 23 Feb. 2019, Japanese, Domestic conference
  • Pembrolizumab投与後に薬剤性筋炎を発症した肺腺癌の1例, 伊藤 優志;笠原 礼光;三浦 陽介;鶴巻 寛朗;矢冨 正清;原 健一郎;櫻井 麗子;砂長 則明;前野 敏孝;久田 剛志, 第60回日本肺癌学会学術集会, 06 Dec. 2019, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • 肺癌におけるWnt/β-catenin経路の恒常的な活性化によるTescalcinの過剰発現, 砂長 則明;三浦 陽介;伊藤 優志;増田 友美;笠原 礼光;櫻井 麗子;久田 剛志, 20191206, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • 当院の外来化学療法センターにおける栄養管理室との連携, 関根 宏美;金城 妙子;本田 理恵;齊賀 桐子;櫻井 麗子;砂長 則明;塚本 憲史, 第60回日本肺癌学会学術集会, 06 Dec. 2019, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • 脈絡膜転移に伴う眼症状を契機に診断された肺腺癌の1例, 櫻井 麗子;伊藤 優志;増田 友美;笠原 礼光;三浦 陽介;砂長 則明;前野 敏孝;久田 剛志, 第60回日本肺癌学会学術総会, 06 Dec. 2019, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • アムルビシン単剤療法が行われた再発小細胞肺癌においてTopoisomerase-II高発現は予後良好因子である, 三浦 陽介;解良 恭一;櫻井 麗子;伊藤 優志;増田 友美;笠原 礼光;砂長 則明;斎藤 龍生;久田 剛志, 第60回日本肺癌学会学術総会, 08 Dec. 2019, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • 超音波気管支鏡ガイド下針生検で診断した肺原発悪性黒色腫の一例, 神宮 飛鳥;原 健太郎;三浦 陽介;矢冨 正清;原 健一郎;櫻井 麗子;砂長 則明;前野 敏孝;久田 剛志, 第60会日本肺癌学会学術総会, 08 Dec. 2019, 06 Dec. 2019, 08 Dec. 2019, Japanese, Domestic conference
  • PD-L1 overexpression induced by oncogenic KRAS and BRAF mutations through MAPK pathway activation in non-small cell lung cancer, Miura, Yosuke;Sunaga, Noriaki;Bao, Pinjie;Girard, Luc;Tsukagoshi, Yusuke;Masuda, Tomomi;Kasahara, Norimitsu;Sakurai, Reiko;Kaira, Kyoichi;Hisada, Takeshi;Minna, John;Yamada, Masanobu, 108th American Association for Cancer Research (ACCR) Annual Meeting, Apr. 2018, 14 Apr. 2018, 18 Apr. 2018, English, International conference
  • Successful treatment with durvalumab, etoposide, and cisplatin in relapsed small cell lung cancer: a case report, Yosuke Miura, Ikuo Wakamatsu, Shogo Uno, Chiharu Hanazato, Tomomi Masuda, Norimitsu Kasahara, Koichi Yamaguchi, Hiroaki Tsurumaki, Haruka Saito, Masakiyo Yatomi, Reiko Sakurai, Yasuhiko K, THE 25TH Congress of the Asia Pacific Society of Respirology., 20 Nov. 2021, 20 Nov. 2021, 21 Nov. 2021
  • AIM2 overexpression and its relationship to KRAS mutations in non-small cell lung cancer., Noriaki Sunaga, Yosuke Miura, Norimitsu Kasahara, Reiko Sakurai, Takeshi Hisada, THE 25TH Congress of the Asia Pacific Society of Respirology., 20 Nov. 2021, 20 Nov. 2021, 21 Nov. 2021

Social Contribution

Social Contribution

  • 令和４年度第２回がん診療連携協議会研修会, 17 Nov. 2022, 17 Nov. 2022, Lecture
  • 第２回がん診療連携協議会研修会, 14 Jan. 2021, 14 Jan. 2021, Lecture　(Target:　Others)
  • 令和3年度第２回がん診療連携協議会研修会, 25 Nov. 2021, 25 Nov. 2021, Lecture　(Target:　Others)

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.